BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 26336810)

  • 21. Transglutaminase-2 regulation by arecoline in gingival fibroblasts.
    Thangjam GS; Agarwal P; Khan I; Verma UP; Balapure AK; Rao SG; Kondaiah P
    J Dent Res; 2009 Feb; 88(2):170-5. PubMed ID: 19278990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
    Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
    J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
    Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
    J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The upregulation of insulin-like growth factor-1 in oral submucous fibrosis.
    Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
    Oral Oncol; 2005 Oct; 41(9):940-6. PubMed ID: 16054426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The upregulation of transglutaminase-2 by cyclosporin a in human gingival fibroblasts is augmented by oxidative stress.
    Lee SS; Tsai CH; Kuan YH; Huang FM; Chang YC
    J Periodontol; 2013 Oct; 84(10):1469-75. PubMed ID: 23173828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of O(6) -methylguanine-DNA methyltransferase in human oral keratinocytes stimulated with arecoline.
    Lee SS; Tsai CH; Yu CC; Ho YC; Hsu HI; Chang YC
    J Oral Pathol Med; 2013 Sep; 42(8):600-5. PubMed ID: 23278137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis.
    Chang YC; Tsai CH; Tai KW; Yang SH; Chou MY; Lii CK
    Oral Oncol; 2002 Jul; 38(5):425-30. PubMed ID: 12110335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
    Shieh DH; Chiang LC; Shieh TY
    Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition.
    Chang MC; Lin LD; Wu HL; Ho YS; Hsien HC; Wang TM; Jeng PY; Cheng RH; Hahn LJ; Jeng JH
    Carcinogenesis; 2013 May; 34(5):1096-104. PubMed ID: 23349021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The upregulation of heat shock protein 70 expression in areca quid chewing-associated oral squamous cell carcinomas.
    Lee SS; Tsai CH; Ho YC; Chang YC
    Oral Oncol; 2008 Sep; 44(9):884-90. PubMed ID: 18234541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan.
    Shieh DH; Chiang LC; Lee CH; Yang YH; Shieh TY
    J Oral Pathol Med; 2004 Oct; 33(9):581-7. PubMed ID: 15357680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The upregulation of cystatin C in oral submucous fibrosis.
    Chung-Hung T; Shun-Fa Y; Yu-Chao C
    Oral Oncol; 2007 Aug; 43(7):680-5. PubMed ID: 17070095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma.
    Yang JS; Chen MK; Yang SF; Chang YC; Su SC; Chiou HL; Chien MH; Lin CW
    Clin Chem Lab Med; 2014 Sep; 52(9):1367-77. PubMed ID: 24695043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The upregulation of metallothionein-1 expression in areca quid chewing-associated oral squamous cell carcinomas.
    Lee SS; Yang SF; Ho YC; Tsai CH; Chang YC
    Oral Oncol; 2008 Feb; 44(2):180-6. PubMed ID: 17418620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis.
    Yang SF; Hsieh YS; Tsai CH; Chen YJ; Chang YC
    Oral Dis; 2007 Mar; 13(2):234-8. PubMed ID: 17305628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated expression of NF-kappaB in oral submucous fibrosis--evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts.
    Ni WF; Tsai CH; Yang SF; Chang YC
    Oral Oncol; 2007 Jul; 43(6):557-62. PubMed ID: 16996785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of heme oxygenase-1 expression in areca-quid-chewing-associated oral squamous cell carcinoma.
    Lee SS; Yang SF; Tsai CH; Chou MC; Chou MY; Chang YC
    J Formos Med Assoc; 2008 May; 107(5):355-63. PubMed ID: 18492619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin.
    Deng YT; Chen HM; Cheng SJ; Chiang CP; Kuo MY
    Oral Oncol; 2009 Sep; 45(9):e99-e105. PubMed ID: 19457704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effects of nicotine on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts.
    Chang YC; Hu CC; Tseng TH; Tai KW; Lii CK; Chou MY
    J Oral Pathol Med; 2001 Sep; 30(8):458-64. PubMed ID: 11545236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral submucous fibrosis: review on aetiology and pathogenesis.
    Tilakaratne WM; Klinikowski MF; Saku T; Peters TJ; Warnakulasuriya S
    Oral Oncol; 2006 Jul; 42(6):561-8. PubMed ID: 16311067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.